A California company is hoping to commercialize software that automates the labor-intensive process of diabetic retinopathy screening, which could save money and prevent large-scale blindness. 

Varun Saxena

Diabetic retinopathy is the leading cause of blindness among working-age adults in the developed world. It can be prevented by screening, but the process of grading retinal images is resource intensive and requires certified optometrists. 

But software to automate the process “represents a fundamental innovation and medical image analysis” and “may have huge potential for telemedicine delivery of eye health care,”...

May 24th, 2016
0

C.R. Bard offers a peek at more than 30 forthcoming products across its businesses, including the peripheral vascular, surgical specialties, and urology divisions. 

Marie Thibault

There's plenty more where that came from.

C. R. Bard has over 150 product ideas in its pipeline but allowed analysts just a taste with a look at approximately 35 new products anticipated in the next few years. The products, which range from tools to help reduce radiation exposure from fluoroscopy to a new dialysis catheter, were described during the company's May 23 analyst meeting.

There are over 150 product ideas in the pre-R&D pipeline and "the...

May 24th, 2016
0

Bundled payment in orthopedics represent an opportunity for smart medical device firms that are not afraid to change how they do business.

Michael Abrams and Gordon Phillips

 

On the morning of April 1, hospital and medical device company executives woke up to yet another new chapter in bundled pricing — CMS’ Comprehensive Care for Joint Replacement (CJR) initiative. Unlike the Bundled Payments for Care Improvement (BPCI) programs that preceded it, there is no opt-out clause for the 800 hospitals designated as participants across the U.S...

May 23rd, 2016
0

The opportunity for cost savings as well as efforts to reduce medical waste are driving rapid growth in the reprocessed medical device market.

Marie Thibault

The worldwide reprocessed medical device market is set to triple to $5 billion by 2022 as healthcare facilities look to cut costs and reduce medical waste. This forecast, from a study by Grand View Research, Inc., anticipates significant growth from the Asia Pacific region. 

The global market is expected to grow at an over 20% compound annual growth rate (CAGR). Almost half (47%) of the $1.141 billion reprocessed medical device market consisted of North American business in 2014, but the report authors...

May 23rd, 2016
0

Procyrion envisions their Aortix device as a less-invasive approach that would keep heart failure patients ambulatory while under treatment.

Marie Thibault

The small Aortix device, under development now, is being designed for the Class III and IVa heart failure patient.

Even though heart failure affects approximately 6 million Americans, there are surprisingly few device treatments and procedures available for these patients. Left ventricular assist devices (LVADs) have received plenty of attention in recent years for their ability to help severe heart failure patients, but the therapy, which requires invasive surgery, can hold little appeal for people who have less severe heart failure. Yet this same...

May 20th, 2016
0

Edwards Lifesciences prevails in a lawsuit involving the transcatheter mitral valve replacement company it acquired and that startup's competitor. 

Arundhati Parmar

The landscape of transcatheter mitral valve replacement to treat mitral valve regurgitation remains unconquered by any company, small or big, but that doesn't mean that patent disputes haven't arisen.

Edwards Lifesciences, which acquired TMVR startup CardiAQ Valve Technologies, announced Thursday that a Massachussets federal jury has found in favor...

May 19th, 2016
0

Here are some key points to know about the devices story emerging from the diversified conglomerate. 

Arundhati Parmar

Investors haven't been too happy with Johnson & Johnson lately with reports of the company getting hit with requests to ramp up its acquisitions and to break up its various businesses. 

Yet, according to recent analyst reports based on an analyst meeting that J&J held Wednesday in New Jersey, the company has been quietly rejiggering its operations, shoring up its strengths and innovating to breathe new life its consumer and medical device business.

Here are five takeaways about the device business of the diversified conglomerate — both consumer facing and hospital facing.

Organizational Makeover to Align With Healthcare Reform...

May 19th, 2016
0

What are the top challenges digital health companies face? The results of a recent survey offer insight into which issues are causing struggles.

Scott Phillips

In 2015 Portland medical device startup Otoharmonics launched a new tinnitus therapy device. The device incorporates a custom earphone and proprietary sound algorithms which are run on an iPad app. Unlike most other digital health devices this is a Class II therapeutic device. 

“As far as we know, this was the first Class II device incorporating an iPad to make it through the FDA 510(k...

May 19th, 2016
0

As connected medical devices become more commonplace, device manufacturers should prepare for helpful hacking and consider how to address potential recalls that may arise.

Kevin Pollack

It’s difficult to argue against the benefits of the Internet of Things (IoT) in the world of medical devices. Connected medical devices can improve patient care, better manage chronic diseases, and lower overall healthcare costs. The industry is growing so much it even has its own acronym: IoT MD.

However, as with any burgeoning industry, there are risks. Connected medical devices are vulnerable to the same sort of coding bugs...

May 17th, 2016
0

Could initiatives like DTSec, a new security standard for connected medical devices, change that?

David Kleidermacher

Throughout the digital world, consumer confidence in service providers’ ability to protect our personal information, our health and well-being, and our critical infrastructure is disappointingly low. Ask 10 random people how they feel about digital security today. Cover your ears before the expletives fly.

Is the outlook improving? Are we winning the war, even if we continue to lose some battles? Hardly: In 2015, the U.S. healthcare industry suffered its five worst ever data breaches while FDA and the Department of Homeland Security issued warnings...

May 16th, 2016
0